CardiologyOnline.net

Cardiology Xagena

Xagena Mappa
Medical Meeting
Reumabase.it
Neurobase.it

The aim of a population-based cohort study was to determine whether the use of angiotensin converting enzyme inhibitors ( ACEIs ), compared with use of angiotensin receptor blockers, is associated wit ...


HeartMate 3 Left Ventricular Assist Device ( LVAD ) has received U.S. Food and Drug Administration ( FDA ) clearance as a destination therapy for people living with advanced heart failure. With th ...


In acute coronary syndrome ( ACS ), potassium imbalance at admission has been associated with in-hospital arrhythmias, cardiac arrest, and mortality. However, several important presentation characte ...


A study has evaluated the influence of anemia on long-term outcomes of patients with acute coronary syndrome undergoing percutaneous coronary intervention ( PCI ). The study included 5668 consecuti ...


The SWEDEHEART ( Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies ) registry routinely collects information on pa ...


Data from the TRANSITION study presented at the European Society of Cardiology ( ESC ) Congress in Munich ( Germany ) has shown that Entresto ( Sacubitril / Valsartan ) can be initiated early and safe ...


Previous studies have shown that low socioeconomic status is associated with a first myocardial infarction, but these findings could not be extended to heart attack survivors to calculate their risk o ...


Mineralocorticoid receptor antagonists ( MRAs ) have been demonstrated to improve outcomes in reduced ejection fraction heart failure ( HFrEF ) patients. However, MRAs added to conventional treatmen ...


Guidelines strongly recommend patients with heart failure with reduced ejection fraction ( HFrEF ) be treated with multiple medications proven to improve clinical outcomes, as tolerated. The degree t ...


Beta-blockers are the cornerstone of therapy for heart failure; however, the effects of these drugs on the prognosis of patients with concomitant atrial fibrillation remain controversial. The obje ...


There are no studies of mineralocorticoid receptor antagonist ( MRA ) treatment examining outcome in unselected real-life patients with myocardial infarction and heart failure. There is uncertainty ...


A study has assessed the relationship between atrial fibrillation and outcomes in the TOPCAT ( Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist ) trial, to evaluat ...


Since the precise mechanism(s) of cognitive disorders in patients with atrial fibrillation ( AF ) is not fully known, the optimal way to prevent cognitive dysfunction for a given patient remains to be ...


Longitudinal studies have shown that dementia is more common in patients diagnosed with atrial fibrillation ( AF ) even in the absence of stroke. A meta-analysis of eight prospective studies evaluat ...


It is well established that atrial fibrillation increases the risk of clinical stroke by four- to five-fold, and patients with a clinical history of stroke are at increased risk of developing dementia ...